Patients often eat much less
Clinical trials show that tirzepatide offers superior weight loss and better metabolic health outcomes
Clinical trials of GLP1 and GIP/GLP1 therapies show meaningful total weight loss, but a slice of that loss comes from fatfree mass (which includes muscle, bone and body water) (Jendle et al., 2022)
By reducing the desire to overeat, it supports healthier relationships with food, which can, in turn, lead to better mental health
Injecting on a Friday evening, for example, means the worst of the digestive effects occur over the weekend when you might be at home rather than in an office environment
Mounjaro (also known as Tirzepatide) is a once-weekly injectable medication that aids weight loss by mimicking the effects of naturally occurring hormones that regulate appetite and food intake